In our study, we showed that 293C3-SDIE allows for the potent induction of NK cell ADCC against MLL-AF4-positive cell lines, as well as against primary leukemic cells of MLL-AF4-rearranged B-ALL patients. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.